183
Views
0
CrossRef citations to date
0
Altmetric
Original Research

Comparison of the effects of local treatment strategies in non-metastatic Ewing sarcoma of bone

, , , , , & show all
Pages 501-506 | Received 27 Jan 2018, Accepted 13 Mar 2018, Published online: 21 Mar 2018

References

  • Rodríguez-Galindo C, Navid F, Liu T, et al. Prognostic factors for local and distant control in Ewing sarcoma family of tumors. Ann Oncol. 2008;19:814–820.
  • Esiashvili N, Goodman M, Marcus RB Jr. Changes in incidence and survival of Ewing sarcoma patients over the past 3 decades: surveillance Epidemiology and end results data. J Pediatr Hematol Oncol. 2008;30:425–430.
  • Grier HE, Krailo MD, Tarbell NJ, et al. Addition of ifosfamide and etoposide to standard chemotherapy for Ewing’s sarcoma and primitive neuroectodermal tumor of bone. N Engl J Med. 2003;348:694–701.
  • Smith MA, Seibel NL, Altekruse SF, et al. Outcomes for children and adolescents with cancer: challenges for the twenty-first century. J Clin Oncol. 2010;28:2625–2634.
  • Howlader N, Noone AM, Krapcho M, et al. SEER Cancer Statistics Review, 1975-2011. Bethesda, MD: National Cancer Institute. Available from: http://seer.cancer.gov/csr/1975_2011/ based on November 2013 SEER data submission, posted to the SEER web site, April 2014 [updated April 2014; cited May 15, 2015].
  • Ozaki T. Diagnosis and treatment of Ewing sarcoma of the bone: a review article. J Orthop Sci. 2015;20:250–263.
  • Rosen G. Progress in the treatment of Ewing sarcoma: are the rumors of the demise of cytotoxic chemotherapy premature? Klin Padiatr. 2015;227:105–107.
  • Surveillance, Epidemiology, and End Results (SEER) Program SEER*Stat Database: incidence - SEER 18 regs research data + Hurricane Katrina Impacted Louisiana Cases, Nov 2014 Sub (1973-2012 varying) - Linked To County Attributes - Total U.S., 1969-2013 Counties, National Cancer Institute, DCCPS, Surveillance Research Program, Surveillance Systems Branch, released April 2015, based on the November 2014 submission [Accessed May 15, 2015]. Available from: www.seer.cancer.gov
  • Cripe TP. Ewing sarcom a: an eponym window to history. Sarcoma. 2011;2011:457532.
  • Hamilton SN, Carlson R, Hasan H, et al. Long-term outcomes and complications in pediatric Ewing sarcoma. Am J Clin Oncol. 2017;40:423–428.
  • Fidler MM, Frobisher C, Guha J, et al. Long-term adverse outcomes in survivors of childhood bone sarcoma: the British childhood cancer survivor study. Br J Cancer. 2015;112:1857–1865.
  • Choi Y, Lim DH, Lee SH, et al. Role of radiotherapy in the multimodal treatment of Ewing sarcoma family tumors. Cancer Res Treat. 2015;47:904–912.
  • Nasaka S, Gundeti S, Ganta RR, et al. Impact of treatment protocol on outcome of localized Ewing’s sarcoma. South Asian J Cancer. 2016;5:194–195.
  • Ozaki T, Hillmann A, Hoffmann C, et al. Significance of surgical margin on the prognosis of patients with Ewing’s sarcoma. A report from the Cooperative Ewing’s Sarcoma Study. Cancer. 1996;78:892–900.
  • Haeusler J, Ranft A, Boelling T, et al. The value of local treatment in patients with primary, disseminated, multifocal Ewing sarcoma (PDMES). Cancer. 2010;116:443–450.
  • Takenaka S, Naka N, Obata H, et al. Treatment outcomes of Japanese patients with Ewing sarcoma: differences between skeletal and extraskeletal Ewing sarcoma. Jpn J Clin Oncol. 2016;46:522–528.
  • Casey DL, Meyers PA, Alektiar KM, et al. Ewing sarcoma in adults treated with modern radiotherapy techniques. Radiother Oncol. 2014;113:248–253.
  • Grevener K, Haveman LM, Ranft A, et al. Management and outcome of Ewing sarcoma of the head and neck. Pediatr Blood Cancer. 2016;63:604–610.
  • DuBois SG, Krailo MD, Gebhardt MC, et al. Comparative evaluation of local control strategies in localized Ewing sarcoma of bone: a report from the children’s oncology group. Cancer. 2015;121:467–475.
  • Becker RG, Gregianin LJ, Galia CR, et al. What is the impact of local control in Ewing sarcoma: analysis of the first Brazilian collaborative study group - EWING1. BMC Cancer. 2017;17:420.
  • Uyeturk U, Helvaci K, Demirci A, et al. Clinical outcomes and prognostic factors of adult’s Ewing sarcoma family of tumors: single center experience. Contemp Oncol (Pozn). 2016;20:141–146.
  • Werier J, Yao X, Caudrelier JM, et al. A systematic review of optimal treatment strategies for localized Ewing’s sarcoma of bone after neo-adjuvant chemotherapy. Surg Oncol. 2016;25:16–23.
  • Bacci G, Ferrari S, Bertoni F, et al. Prognostic factors in nonmetastatic Ewing’s sarcoma of bone treated with adjuvant chemotherapy: analysis of 359 patients at the Istituto Ortopedico Rizzoli. J Clin Oncol. 2000;18:4–11.
  • Jawad MU, Haleem AA, Scully SP. Malignant sarcoma of the pelvic bones: treatment outcomes and prognostic factors vary by histopathology. Cancer. 2011;117:1529–1541.
  • Bacci G, Boriani S, Balladelli A, et al. Treatment of nonmetastatic Ewing’s sarcoma family tumors of the spine and sacrum: the experience from a single institution. Eur Spine J. 2009;18:1091–1095.
  • Raciborska A, Bilska K, Rychlowska-Pruszynska M, et al. Internal hemipelvectomy in the management of pelvic Ewing sarcoma - are outcomes better than with radiation therapy? J Pediatr Surg. 2014;49:1500–1504.
  • Biswas B, Rastogi S, Khan SA, et al. Developing a prognostic model for localized Ewing sarcoma family of tumors: a single institutional experience of 224 cases treated with uniform chemotherapy protocol. J Surg Oncol. 2015;111:683–689.
  • Indelicato DJ, Keole SR, Shahlaee AH, et al. Definitive radiotherapy for Ewing tumors of extremities and pelvis: long-term disease control, limb function, and treatment toxicity. Int J Radiat Oncol Biol Phys. 2008;72:871–877.
  • Huh WW, Daw NC, Herzog CE, et al. Ewing sarcoma family of tumors in children younger than 10 years of age. Pediatr Blood Cancer. 2017;64:e26275.
  • Duchman KR, Gao Y, Miller BJ. Prognostic factors for survival in patients with Ewing’s sarcoma using the surveillance, epidemiology, and end results (SEER) program database. Cancer Epidemiol. 2015;39:189–195.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.